Complete regression of recurrent esophageal carcinoma with reduced expression of glutathione S-transferase-π by treatment with continuous infusion of 5-fluorouracil and low-dose cisplatin infusion

American Journal of Gastroenterology

Volumn 94, Issue 6, 1999, Pages 1664-1668

  Tominaga, Kazunari ^a   Arakawa, Tetsuo ^a   Imano, Motohiro ^b   Kato, Michio ^b   Hamaguchi, Yuko ^a   Watanabe, Toshio ^a   Takaishi, Osamu ^a   Fujiwara, Yasuhiro ^a   Fukuda, Takashi ^a   Higuchi, Kazuhide ^a   Osugi, Harushi ^a   Chono, Shinji ^c   Kuroki, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Machida Gastrointestinal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; ENDOSCOPIC BIOPSY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MORTALITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; INFUSION PUMPS; ISOENZYMES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032974693     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00215-4     Document Type: Article

References (23)

1. Schabel F.M., Trader M.W., Laster W.R., et al. Cis-Dichlorodiammineplatinum (II) Combination chemotherapy and cross-resistance studies with tumors of mice . Cancer Treat Rep. 63:1979;1459-1473.
2. Rooney M., Kish J., Jacobs J., et al. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer. 55:1985;1123-1128.
3. Lokich J.J., Ahlgren J.D., Gullo J.J., et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma A mid-atlantic oncology program study . J Clin Oncol. 7:1989;425-432.
4. Moynihan T., Hansen R., Anderson T., et al. Continuous 5-fluorouracil infusion in advanced gastric carcinoma. Am J Clin Oncol. 11:1988;461-464.
5. Kish J.A., Ensley J.F., Jacobs J., et al. A randomized trial of cisplatin + 5-FU infusion and cisplatin + 5-FU bolus for recurrent and advanced squamous cell carcinoma of head and neck. Cancer. 56:1985;2740-2744.
6. Keith W.N., Stallard S., Brown R., et al. Expression of mdr1 and GSTπ in human breast tumors Comparison to in vitro chemosensitivity . Br J Cancer. 61:1990;712-716.
7. Holmes J., Wareing C., Jacobs A., et al. Glutathione S-transferase π expression in leukemia A comparative analysis with mdr-1 data . Br J Cancer. 62:1990;209-212.
8. Mistry P., Kelland L.R., Abel G., et al. The relationship between glutathione, glutathione-S-transferase and cytotoxity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br J Cancer. 64:1991;215-220.
9. de Vries E.G.E., Meijer C., Timmer-Bosscha H., et al. Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up. Cancer Res. 49:1989;4175-4178.
10. Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. 8th ed. 1992;Kanehara, Tokyo.
11. Manual for staging of cancer. 4th ed. 1992;JB Lippincott, Philadelphia.
12. Zubrod G.C., Scheideman M., Frei E. III, et al. Appraisal of methods for the study of chemotherapy of cancer in man Comparative therapeutic trial of nitrogen mustard and triethlene thio phosphoramide . J Chron Dis. 11:1960;7-33.
13. Terrier P., Townsend A.J., Coindre J.M., et al. An immunohistochemical study of π class glutathion S-transferase expression in normal human tissue. Am J Pathol. 137:1990;845-853.
14. Okuyama T., Maehara Y., Endo K., et al. Expression of glutathione S-transferase-π and sensitivity of human gastric cancer cells to cisplatin. Cancer. 74:1994;1230-1236.
15. Kelsen D.P., Bains M., Hilaris B., et al. Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycine. Cancer. 49:1982;1174-1177.
16. Iizuka T., Kakegawa T., Ide H., et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus. A Japanese esophageal oncology trial. Jpn J Clin Oncol. 22:1992;172-176.
17. Chung Y.S., Yamashita Y., Inoue T., et al. Continuous infusion of 5-fluorouracil and low-dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma. Cancer. 80:1997;1-7.
18. Yamashita Y., Chung Y.S., Kato Y., et al. Combination therapy of low dose (continuous) 5-FU and low dose (daily) CDDP for advanced and recurrent digestive cancer. J Jpn Soc Cancer Ther. 29:1994;1927-1933.
19. Muhktar H., Bresnick E. Glutathione-S-epoxide transferase activity during development and the effect of partial hepatectomy. Cancer Res. 36:1976;937-940.
20. Clifton G., Kaplowitz N. The glutathione S-transferases of the small intestine in the rat. Cancer Res. 37:1977;788-791.
21. Saburi Y., Nakagawa M., Ono M., et al. Increased expression of glutathione S-transferase gene in cis-diamminedic chloroplatinum (II)-resistant variants of a Chinese hamster ovary cell line. Cancer Res. 49:1989;7020-7025.
22. Satta T., Isobe K., Yamauchi M., et al. Expression of MDR1 and glutathione S-transferase π genes and chemosensitivities in human gastrointestinal cancer. Cancer. 69:1992;941-946.
23. Teicher B.A., Holden S.A., Kelley M.J., et al. Characterization of a human squamous carcinoma cell line resistant to cis-Diammimmine dichloroplatinum (II). Cancer Res. 47:1987;388-393.